IDE-196 Uses, Dosage, Side Effects and more
IDE-196 is under investigation in clinical trial NCT03947385 (Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions).
| Trade Name | IDE-196 |
| Generic | IDE-196 |
| Type | |
| Formula | C22H23F3N8O |
| Weight | Average: 472.476 Monoisotopic: 472.194691882 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
